Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million Series B financing. The...
Every technology category has its breakout moment: the point where the market shifts, adoption accelerates, and the winner begins to separate from the pack....
Plastomics, a cutting-edge leader in agricultural biotechnology, today announced the successful initial close of its Series B funding round, securing $5.8 million to fuel...
Peptilogics, a clinical-stage biotechnology company developing transformative surgical therapeutics to effectively treat and prevent serious medical device infections, today announced the completion of an...
Stand, the company reimagining insurance for catastrophe-exposed properties, today announced the close of its $35 million Series B funding round. The round was led...
BridGene Biosciences, Inc., a leader in the discovery and development of small molecule drugs for traditionally “hard-to-drug” targets, today announced the recent completion of...
Less than two years ago, Reducto released the first Parse API to combine the best of traditional computer vision and Vision-Language Models (VLMs). We...
